Long term performance characteristics of an electrochemical nitric oxide analyser

Summary Background The NIOX MINO® is a nitric oxide (FENO ) analyser based on electrochemical technology. It includes a replaceable sensor. Quality control procedures are recommended, but regular calibration is not possible. We aimed to evaluate the performance characteristics of the NIOX MINO® to i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory medicine 2011-02, Vol.105 (2), p.211-217
Hauptverfasser: Taylor, D. Robin, Palmay, Rochelle, Cowan, Jan O, Herbison, G. Peter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Background The NIOX MINO® is a nitric oxide (FENO ) analyser based on electrochemical technology. It includes a replaceable sensor. Quality control procedures are recommended, but regular calibration is not possible. We aimed to evaluate the performance characteristics of the NIOX MINO® to identify if reproducibility changed over time, or with different sensors. Also, there are reports that reproducibility of FENO may be reduced in patients with high FENO : our secondary aim was to address this issue. Methods Reproducibility in 24 separate sensor-analyser units was calculated on three occasions over two months in 17 patients. These included 9 patients whose FENO was high (mean 80 ppb) and 8 in whom FENO was low (mean 16 ppb). Results One device failed quality control testing. For the remaining 23 sensor-analyser combinations, the mean coefficient of variation was 4.0% (range 1.2–7.2%) at baseline, 3.6% (range 2.0–7.0) at one month, and 3.6% (range 1.6–7.6%) at two months. The 95% C.I. for the mean limits of agreement for FENO was ±4.2 ppb (range 0.9–9.6 ppb), ±3.8 ppb (range 1.6–6.9 ppb) and ±3.2 ppb (range 1.2–6.8 ppb) respectively (NS). The limits of agreement exceeded the manufacturer’s specifications (±5 ppb) in 0 devices at baseline, 3 (13%) at one month, and 5 (22%) at two months. Conclusions Reproducibility of FENO using the NIOX MINO® was within clinically acceptable limits (±10 ppb) and was generally stable. However, with time, a proportion of individual sensor-analyser combinations yielded variability outside the manufacturer’s specifications.
ISSN:0954-6111
1532-3064
DOI:10.1016/j.rmed.2010.09.001